ANTITHROMBOTIC PREVENTION IN WOMEN WITH MEDICAL HISTORY SIGNIFICANT FOR OBSTETRIC AND THROMBOTIC EVENTS. CLINICAL OBSERVATION
https://doi.org/10.21518/2079-701X-2017-13-34-37
Abstract
The article presents a clinical case of management of pregnancy in a woman with medical history signficant for obstetric and thrombotic events. After a thorough examination of the hemostatic system the role of genetic and acquired thrombophilia was identified. From a modern point of view thrombophilia is considered to be the etiopathogenetic factor for a wide range of diseases and syndromes – fetal loss syndrome, preeclampsia, thromboembolic complications of hormonal contraception and hormonal replacement therapy. The role of anticoagulant and antiplatelet therapy is discussed, in particular the use of dipyridamole in obstetric practice.
About the Author
D. K. Khizroeva
Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
PhD in medicine, Prof.,
Moscow
References
1. Ciacciarelli M, Zerbinati C, Violi F, Iuliano L. Dipyridamole: a drug with unrecognized antioxidant activity. Curr Top Med Chem, 2015, 15(9): 822-9.
2. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews, 2007.
3. Iuliano L, Colavita AR, Camastra C, Bello V, Quintarelli C, Alessandroni M, Piovella F, Violi F. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Br J Pharmacol, 1996 Dec, 119(7): 1438-46.
4. Kam A, Razmovski-Naumovski V, Zhou X, Troung J, Chan K.Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine. J Pharm Pharm Sci, 2015, 18(5): 871-81.
5. Massaro M, Scoditti E, Carluccio MA, Pellegrino M, Calabriso N, Storelli C, Martines G, De Caterina R. Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes. Thromb Haemost, 2013 Feb, 109(2): 280-9. doi: 10.1160/TH12-05-0326.
6. Taddei S, Arzilli F, Arrighi P, Salvetti A. Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients. Am J Hypertens, 1992 Jan, 5(1): 29-31.
7. Yarrington CD, Valente AM, Economy KE. Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents. Circulation, 2015 Oct 6, 132(14): 1354-64.
Review
For citations:
Khizroeva DK. ANTITHROMBOTIC PREVENTION IN WOMEN WITH MEDICAL HISTORY SIGNIFICANT FOR OBSTETRIC AND THROMBOTIC EVENTS. CLINICAL OBSERVATION. Meditsinskiy sovet = Medical Council. 2017;(13):34-37. (In Russ.) https://doi.org/10.21518/2079-701X-2017-13-34-37
Views:
522
Email this article 